Wu, J., Zhou, X., Tan, Y., Wang, L., Li, T., Li, Z., . . . Hu, B. (2020). Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs. Cell Prolif.
Chicago ZitierstilWu, Jun, et al. "Phase 1 Trial for Treatment of COVID‐19 Patients With Pulmonary Fibrosis Using HESC‐IMRCs." Cell Prolif 2020.
MLA ZitierstilWu, Jun, et al. "Phase 1 Trial for Treatment of COVID‐19 Patients With Pulmonary Fibrosis Using HESC‐IMRCs." Cell Prolif 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.